• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,822.91 -0.29
(0.00%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Aarti Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524348
INE767A01016
136.1848045
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIDRUGS
28.48
4480.45
EPS(TTM)
Face Value()
Div & Yield %
17.11
10
0.2
 

tata consultancy services ltd
Bharat Forge gains after acquiring AAM India manufacturing
Jul 02,2025
The equity value includes cash on books of the acquired entity of Rs 189.48 crore. This cash is available for addressing future growth opportunities.

The company said the acquisition will enable to complement its component offerings with products solutions to OEMs in India & Globally.

On 17 October 2024, the company had entered into a share purchase agreement to acquire 100% stake in AAM India Manufacturing. As part of the transaction, Bharat Forge will take over AAMIMCPL’s commercial vehicle (CV) axle business, including its manufacturing facilities in Pune and Chennai, as well as the Pune Engineering & Development Centre.

Bharat Forge (BFL), a Pune-based Indian multinational, is a technology driven global leader in providing high performance, innovative safety critical components and solutions for several sectors including automotive, power, oil and gas, construction & mining, rail, marine, defense and aerospace.

The company’s consolidated net profit jumped 19.5% to Rs 282 crore despite a 7.5% decline in net sales to Rs 3,852.60 crore in Q4 FY25 over Q4 FY24.